Form EFFECT AMICUS THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016987 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BrainCheck Selected for Three Poster Presentations at the 2026 Alzheimer’s Association International Conference
- Syntec Optics (NASDAQ: OPTX) Secures 40% Increase in Orders for Missile Laser Guidance Product Line
- Bright Power Earns 2026 Great Place To Work Certification
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
